Zacks Investment Research downgraded shares of ACACIA RES-TECH (ACTG) from NEUTRAL to UNDERPERFORM on November 09, 2012, with a target price of $21.70.
Acacia Research develops, licenses and provides products for the life science and media technology sectors. Acacia licenses its V-chip technology to television manufacturers and owns pioneering technology for digital streaming and video-on-demand. Acacia's CombiMatrix subsidiary is developing a bio-chip technology for the life science market.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on ACACIA RES-TECH (ACTG),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment